138 related articles for article (PubMed ID: 38764268)
1. Progress on mechanisms of antibiotic resistance in Clostridioides difficile.
Teng X; Hai-Hui H
Yi Chuan; 2023 Nov; 45(11):1028-1038. PubMed ID: 38764268
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance in Clostridioides difficile.
O'Grady K; Knight DR; Riley TV
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2459-2478. PubMed ID: 34427801
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
Kolte B; Nübel U
J Antimicrob Chemother; 2024 Jun; 79(6):1320-1328. PubMed ID: 38598696
[TBL] [Abstract][Full Text] [Related]
4. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
5. The
Wickramage I; Peng Z; Chakraborty S; Harmanus C; Kuijper EJ; Alrabaa S; Smits WK; Sun X
Microbiol Spectr; 2023 Jun; 11(3):e0377722. PubMed ID: 37125917
[TBL] [Abstract][Full Text] [Related]
6. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
[TBL] [Abstract][Full Text] [Related]
7. Diversity of Circulating
Martínez-Meléndez A; Tijerina-Rodríguez L; Collins N; Baines SD; Morfin-Otero R; Camacho-Ortíz A; Villarreal-Treviño L; Garza-González E
Microb Drug Resist; 2021 Dec; 27(12):1672-1676. PubMed ID: 34037477
[TBL] [Abstract][Full Text] [Related]
8. Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.
Costa DVS; Pham NVS; Hays RA; Bolick DT; Goldbeck SM; Poulter MD; Hoang SC; Shin JH; Wu M; Warren CA
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0048922. PubMed ID: 35861541
[TBL] [Abstract][Full Text] [Related]
9. Toxin genotypes, antibiotic resistance and their correlations in Clostridioides difficile isolated from hospitals in Xi'an, China.
Zhang S; Ma C; Zhang H; Zhao C; Guo R; Liu J; Wang J; Yuan J; Jia K; Wu A; Chen Y; Lei J
BMC Microbiol; 2024 May; 24(1):177. PubMed ID: 38783194
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
Jon J V; Mark H W; Jane F
Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
[TBL] [Abstract][Full Text] [Related]
11. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
Collins DA; Riley TV
Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
[TBL] [Abstract][Full Text] [Related]
13. Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile.
Pu M; Cho JM; Cunningham SA; Behera GK; Becker S; Amjad T; Greenwood-Quaintance KE; Mendes-Soares H; Jones-Hall Y; Jeraldo PR; Chen J; Dunny G; Patel R; Kashyap PC
Gastroenterology; 2021 Feb; 160(3):941-945.e8. PubMed ID: 33197449
[TBL] [Abstract][Full Text] [Related]
14. Plasmid-mediated metronidazole resistance in Clostridioides difficile.
Boekhoud IM; Hornung BVH; Sevilla E; Harmanus C; Bos-Sanders IMJG; Terveer EM; Bolea R; Corver J; Kuijper EJ; Smits WK
Nat Commun; 2020 Jan; 11(1):598. PubMed ID: 32001686
[TBL] [Abstract][Full Text] [Related]
15. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.
Abujamel T; Cadnum JL; Jury LA; Sunkesula VC; Kundrapu S; Jump RL; Stintzi AC; Donskey CJ
PLoS One; 2013; 8(10):e76269. PubMed ID: 24098459
[TBL] [Abstract][Full Text] [Related]
16. Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?
Krutova M; Wilcox M; Kuijper E
Int J Infect Dis; 2022 Nov; 124():118-123. PubMed ID: 36155825
[TBL] [Abstract][Full Text] [Related]
17. Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water.
Cizek A; Masarikova M; Mares J; Brajerova M; Krutova M
Microbiol Spectr; 2022 Aug; 10(4):e0080622. PubMed ID: 35950844
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fidaxomicin, thuricin CD, vancomycin and nisin highlights the narrow spectrum nature of thuricin CD.
Walsh L; Lavelle A; O'Connor PM; Hill C; Ross RP
Gut Microbes; 2024; 16(1):2342583. PubMed ID: 38722061
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of
Bassères E; Eubank TA; Begum K; Alam MJ; Jo J; Le TM; Lancaster CK; Gonzales-Luna AJ; Garey KW
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0162123. PubMed ID: 38364016
[TBL] [Abstract][Full Text] [Related]
20. Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.
Turner NA; Warren BG; Gergen-Teague MF; Addison RM; Addison B; Rutala WA; Weber DJ; Sexton DJ; Anderson DJ
Clin Infect Dis; 2022 Mar; 74(4):648-656. PubMed ID: 34017999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
